Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rifaximin Therapy on Brain Activation in Patients With Minimal Hepatic Encephalopathy Using Functional MR, MR Spectroscopy,Diffusion Tensor Imaging Microbiome and Metabolome: a Prospective Trial

NCT01069133 is registered in ClinicalTrials.gov with Hunter Holmes Mcguire Veteran Affairs Medical Center as lead sponsor.

NCT NCT01069133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rifaximin Therapy on Brain Activation in Patients With Minimal Hepatic Encephalopathy Using Functional MR, MR Spectroscopy,Diffusion Tensor Imaging Microbiome and Metabolome: a Prospective Trial
Lead sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2010
Completion date
December 31, 2012
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

minimal hepatic encephalopathy